OraSure Technologies, Inc. (OSUR)
USD 2.93
(-0.34%)
USD 2.93
(-0.34%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 53.65 Million USD | 399.16% |
| 2022 | -17.93 Million USD | 22.01% |
| 2021 | -22.99 Million USD | -54.12% |
| 2020 | -14.92 Million USD | -189.59% |
| 2019 | 16.65 Million USD | -18.34% |
| 2018 | 20.39 Million USD | -34.1% |
| 2017 | 30.94 Million USD | 56.94% |
| 2016 | 19.72 Million USD | 141.46% |
| 2015 | 8.16 Million USD | 277.0% |
| 2014 | -4.61 Million USD | 58.77% |
| 2013 | -11.19 Million USD | 25.97% |
| 2012 | -15.11 Million USD | -70.96% |
| 2011 | -8.84 Million USD | -152.82% |
| 2010 | -3.49 Million USD | 55.24% |
| 2009 | -7.81 Million USD | 75.02% |
| 2008 | -31.27 Million USD | -1364.96% |
| 2007 | 2.47 Million USD | -53.06% |
| 2006 | 5.26 Million USD | -80.81% |
| 2005 | 27.44 Million USD | 5004.58% |
| 2004 | -559.64 Thousand USD | 50.72% |
| 2003 | -1.13 Million USD | 66.03% |
| 2002 | -3.34 Million USD | 10.34% |
| 2001 | -3.72 Million USD | 70.75% |
| 2000 | -12.74 Million USD | -298.33% |
| 1999 | -3.2 Million USD | -68.42% |
| 1998 | -1.9 Million USD | 91.56% |
| 1997 | -22.5 Million USD | -7400.0% |
| 1996 | -300 Thousand USD | 98.38% |
| 1995 | -18.5 Million USD | -18.59% |
| 1994 | -15.6 Million USD | -6.12% |
| 1993 | -14.7 Million USD | -104.17% |
| 1992 | -7.2 Million USD | -46.94% |
| 1991 | -4.9 Million USD | -68.97% |
| 1990 | -2.9 Million USD | -11.54% |
| 1989 | -2.6 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.58 Million USD | -117.85% |
| 2024 Q2 | -615 Thousand USD | 82.84% |
| 2023 FY | 53.65 Million USD | 399.16% |
| 2023 Q4 | 20.07 Million USD | 79.88% |
| 2023 Q2 | -4.79 Million USD | -117.62% |
| 2023 Q1 | 27.21 Million USD | 74.91% |
| 2023 Q3 | 11.15 Million USD | 332.67% |
| 2022 Q4 | 15.56 Million USD | 195.13% |
| 2022 Q1 | -19.96 Million USD | -92.12% |
| 2022 Q2 | -18.8 Million USD | 5.83% |
| 2022 FY | -17.93 Million USD | 22.01% |
| 2022 Q3 | 5.27 Million USD | 128.04% |
| 2021 Q2 | -1.36 Million USD | -136.14% |
| 2021 Q3 | -15.01 Million USD | -1000.81% |
| 2021 Q1 | 3.77 Million USD | 102.9% |
| 2021 Q4 | -10.39 Million USD | 30.78% |
| 2021 FY | -22.99 Million USD | -54.12% |
| 2020 Q1 | -7.32 Million USD | -400.57% |
| 2020 FY | -14.92 Million USD | -189.59% |
| 2020 Q2 | -10.49 Million USD | -43.2% |
| 2020 Q3 | 1.04 Million USD | 109.91% |
| 2020 Q4 | 1.86 Million USD | 78.85% |
| 2019 FY | 16.65 Million USD | -18.34% |
| 2019 Q4 | 2.43 Million USD | -81.36% |
| 2019 Q1 | -3.25 Million USD | -131.64% |
| 2019 Q3 | 13.07 Million USD | 197.36% |
| 2019 Q2 | 4.39 Million USD | 234.99% |
| 2018 Q2 | 4.12 Million USD | 294.48% |
| 2018 FY | 20.39 Million USD | -34.1% |
| 2018 Q3 | 8.09 Million USD | 96.46% |
| 2018 Q4 | 10.29 Million USD | 27.2% |
| 2018 Q1 | -2.11 Million USD | -128.96% |
| 2017 Q2 | 5.42 Million USD | -56.37% |
| 2017 FY | 30.94 Million USD | 56.94% |
| 2017 Q4 | 7.31 Million USD | 26.95% |
| 2017 Q3 | 5.76 Million USD | 6.17% |
| 2017 Q1 | 12.44 Million USD | 72.89% |
| 2016 Q1 | 2.44 Million USD | -47.01% |
| 2016 Q2 | 3.83 Million USD | 56.83% |
| 2016 FY | 19.72 Million USD | 141.46% |
| 2016 Q3 | 6.24 Million USD | 62.72% |
| 2016 Q4 | 7.19 Million USD | 15.28% |
| 2015 FY | 8.16 Million USD | 277.0% |
| 2015 Q4 | 4.61 Million USD | 214.01% |
| 2015 Q3 | 1.47 Million USD | -25.3% |
| 2015 Q1 | 113 Thousand USD | 104.26% |
| 2015 Q2 | 1.96 Million USD | 1641.59% |
| 2014 FY | -4.61 Million USD | 58.77% |
| 2014 Q1 | -5.63 Million USD | -190.63% |
| 2014 Q4 | -2.65 Million USD | -332.63% |
| 2014 Q3 | 1.14 Million USD | -54.92% |
| 2014 Q2 | 2.52 Million USD | 144.91% |
| 2013 Q4 | 6.21 Million USD | 428.38% |
| 2013 Q3 | -1.89 Million USD | 64.2% |
| 2013 Q2 | -5.28 Million USD | 48.32% |
| 2013 FY | -11.19 Million USD | 25.97% |
| 2013 Q1 | -10.22 Million USD | -74.33% |
| 2012 Q4 | -5.86 Million USD | -140.9% |
| 2012 Q3 | -2.43 Million USD | 31.64% |
| 2012 Q2 | -3.56 Million USD | -9.53% |
| 2012 Q1 | -3.25 Million USD | -2921.47% |
| 2012 FY | -15.11 Million USD | -70.96% |
| 2011 Q3 | -3.91 Million USD | -60.75% |
| 2011 FY | -8.84 Million USD | -152.82% |
| 2011 Q4 | 115.25 Thousand USD | 102.94% |
| 2011 Q2 | -2.43 Million USD | 6.16% |
| 2011 Q1 | -2.59 Million USD | -154.04% |
| 2010 Q4 | -1.02 Million USD | -473.32% |
| 2010 FY | -3.49 Million USD | 55.24% |
| 2010 Q1 | -2.19 Million USD | 22.57% |
| 2010 Q2 | -553 Thousand USD | 74.81% |
| 2010 Q3 | 273.95 Thousand USD | 149.54% |
| 2009 Q1 | -1.61 Million USD | 94.47% |
| 2009 FY | -7.81 Million USD | 75.02% |
| 2009 Q2 | -5.15 Million USD | -218.9% |
| 2009 Q4 | -2.83 Million USD | -257.55% |
| 2009 Q3 | 1.79 Million USD | 134.87% |
| 2008 Q3 | -1.76 Million USD | 21.47% |
| 2008 FY | -31.27 Million USD | -1364.96% |
| 2008 Q1 | 2 Million USD | 7231.83% |
| 2008 Q2 | -2.24 Million USD | -212.07% |
| 2008 Q4 | -29.27 Million USD | -1561.63% |
| 2007 Q1 | 1.48 Million USD | 45.01% |
| 2007 FY | 2.47 Million USD | -53.06% |
| 2007 Q2 | 954.55 Thousand USD | -35.79% |
| 2007 Q4 | 27.3 Thousand USD | 572.63% |
| 2007 Q3 | 4059.00 USD | -99.57% |
| 2006 Q4 | 1.02 Million USD | -51.97% |
| 2006 FY | 5.26 Million USD | -80.81% |
| 2006 Q2 | 1.2 Million USD | 34.3% |
| 2006 Q3 | 2.13 Million USD | 76.67% |
| 2006 Q1 | 899.63 Thousand USD | -95.64% |
| 2005 Q2 | 1.44 Million USD | -7.6% |
| 2005 FY | 27.44 Million USD | 5004.58% |
| 2005 Q4 | 20.63 Million USD | 441.9% |
| 2005 Q3 | 3.8 Million USD | 163.96% |
| 2005 Q1 | 1.56 Million USD | 736.03% |
| 2004 FY | -559.64 Thousand USD | 50.72% |
| 2004 Q4 | -245.48 Thousand USD | 16.52% |
| 2004 Q3 | -294.07 Thousand USD | -306.91% |
| 2004 Q2 | 142.12 Thousand USD | 187.62% |
| 2004 Q1 | -162.21 Thousand USD | -137.29% |
| 2003 Q2 | -530.25 Thousand USD | 51.48% |
| 2003 Q1 | -1.09 Million USD | -1236.08% |
| 2003 Q3 | 52.61 Thousand USD | 109.92% |
| 2003 Q4 | 434.95 Thousand USD | 726.63% |
| 2003 FY | -1.13 Million USD | 66.03% |
| 2002 FY | -3.34 Million USD | 10.34% |
| 2002 Q4 | -81.79 Thousand USD | 78.86% |
| 2002 Q2 | -1.28 Million USD | 19.56% |
| 2002 Q1 | -1.59 Million USD | 30.83% |
| 2002 Q3 | -386.84 Thousand USD | 69.8% |
| 2001 Q4 | -2.3 Million USD | -14805.01% |
| 2001 Q1 | -996.75 Thousand USD | 72.71% |
| 2001 Q3 | 15.65 Thousand USD | 103.53% |
| 2001 Q2 | -444.17 Thousand USD | 55.44% |
| 2001 FY | -3.72 Million USD | 70.75% |
| 2000 FY | -12.74 Million USD | -298.33% |
| 2000 Q4 | -3.65 Million USD | 53.91% |
| 2000 Q3 | -7.92 Million USD | -3559.73% |
| 2000 Q2 | -216.51 Thousand USD | 76.19% |
| 2000 Q1 | -909.46 Thousand USD | -77.14% |
| 1999 FY | -3.2 Million USD | -68.42% |
| 1999 Q4 | -513.42 Thousand USD | 42.95% |
| 1999 Q3 | -900 Thousand USD | -12.5% |
| 1999 Q2 | -800 Thousand USD | 0.0% |
| 1999 Q1 | -800 Thousand USD | -14.29% |
| 1998 Q3 | - USD | 100.0% |
| 1998 FY | -1.9 Million USD | 91.56% |
| 1998 Q1 | -700 Thousand USD | 30.0% |
| 1998 Q2 | -300 Thousand USD | 57.14% |
| 1998 Q4 | -700 Thousand USD | 0.0% |
| 1997 FY | -22.5 Million USD | -7400.0% |
| 1997 Q4 | -1 Million USD | 82.14% |
| 1997 Q3 | -5.6 Million USD | -143.48% |
| 1997 Q2 | -2.3 Million USD | 77.23% |
| 1997 Q1 | -10.1 Million USD | -124.44% |
| 1996 FY | -300 Thousand USD | 98.38% |
| 1996 Q4 | -4.5 Million USD | 0.0% |
| 1996 Q3 | - USD | -100.0% |
| 1996 Q2 | 3.5 Million USD | 294.44% |
| 1996 Q1 | -1.8 Million USD | -5.88% |
| 1995 Q3 | -5.2 Million USD | -26.83% |
| 1995 Q2 | -4.1 Million USD | 14.58% |
| 1995 Q1 | -4.8 Million USD | -11.63% |
| 1995 FY | -18.5 Million USD | -18.59% |
| 1995 Q4 | -1.7 Million USD | 67.31% |
| 1994 FY | -15.6 Million USD | -6.12% |
| 1994 Q4 | -4.3 Million USD | 4.44% |
| 1994 Q3 | -4.5 Million USD | -18.42% |
| 1994 Q2 | -3.8 Million USD | 13.64% |
| 1994 Q1 | -4.4 Million USD | -51.72% |
| 1993 Q1 | -4.6 Million USD | -48.39% |
| 1993 FY | -14.7 Million USD | -104.17% |
| 1993 Q2 | -3.3 Million USD | 28.26% |
| 1993 Q3 | -3.6 Million USD | -9.09% |
| 1993 Q4 | -2.9 Million USD | 19.44% |
| 1992 Q4 | -3.1 Million USD | -29.17% |
| 1992 Q2 | -1.6 Million USD | 0.0% |
| 1992 Q3 | -2.4 Million USD | -50.0% |
| 1992 FY | -7.2 Million USD | -46.94% |
| 1992 Q1 | -1.6 Million USD | 5.88% |
| 1991 FY | -4.9 Million USD | -68.97% |
| 1991 Q1 | -1.2 Million USD | -50.0% |
| 1991 Q2 | -1.1 Million USD | 8.33% |
| 1991 Q3 | -1.8 Million USD | -63.64% |
| 1991 Q4 | -1.7 Million USD | 5.56% |
| 1990 Q3 | -400 Thousand USD | 63.64% |
| 1990 FY | -2.9 Million USD | -11.54% |
| 1990 Q1 | -800 Thousand USD | -60.0% |
| 1990 Q2 | -1.1 Million USD | -37.5% |
| 1990 Q4 | -800 Thousand USD | -100.0% |
| 1989 Q2 | -600 Thousand USD | 0.0% |
| 1989 FY | -2.6 Million USD | 0.0% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q4 | -500 Thousand USD | -25.0% |
| 1989 Q3 | -400 Thousand USD | 33.33% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 184.732% |
| AngioDynamics, Inc. | -184.34 Million USD | 129.105% |
| AtriCure, Inc. | -30.43 Million USD | 276.276% |
| Avinger, Inc. | -18.32 Million USD | 392.877% |
| Azenta, Inc. | -14.25 Million USD | 476.341% |
| BioLife Solutions, Inc. | -66.42 Million USD | 180.773% |
| The Cooper Companies, Inc. | 294.2 Million USD | 81.762% |
| Daxor Corporation | 280.64 Thousand USD | -19018.8% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 453.04% |
| Femasys Inc. | -14.24 Million USD | 476.602% |
| GlucoTrack, Inc. | -7.09 Million USD | 856.024% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 1671.157% |
| Hologic, Inc. | 789.5 Million USD | 93.204% |
| ICU Medical, Inc. | -29.65 Million USD | 280.931% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 97.016% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 490.472% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | -78.226% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 905.216% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 905.216% |
| Masimo Corporation | 81.5 Million USD | 34.166% |
| Microbot Medical Inc. | -10.74 Million USD | 599.581% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | -361.532% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 43.169% |
| Nephros, Inc. | -1.57 Million USD | 3506.667% |
| NovoCure Limited | -207.04 Million USD | 125.915% |
| NEXGEL, Inc. | -3.15 Million USD | 1799.557% |
| NEXGEL, Inc. | -3.15 Million USD | 1799.557% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 156.586% |
| Pro-Dex, Inc. | 2.12 Million USD | -2422.567% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 227.114% |
| Predictive Oncology Inc. | -13.98 Million USD | 483.689% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 1917.965% |
| QuidelOrtho Corporation | -10.1 Million USD | 631.238% |
| Repligen Corporation | 41.57 Million USD | -29.05% |
| Sanara MedTech Inc. | -4.3 Million USD | 1346.864% |
| STAAR Surgical Company | 21.34 Million USD | -151.347% |
| Sharps Technology, Inc. | -9.84 Million USD | 645.184% |
| Utah Medical Products, Inc. | 16.63 Million USD | -222.543% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 140.648% |
| Jin Medical International Ltd. | 2.87 Million USD | -1764.167% |